Pharma and healthcare, 24 Oct 2024

From left: Atul Suri, Bhavna Kewalramani and Praful Akali

24 Oct 2024 11:22 AM

Panel Discussion: Evidence-based science crucial to reach decision-makers in the pharma industry

In conversation with Bhavna Kewalramani, Sanofi India and Atul Suri, Alembic Pharmaceuticals.

Latest Stories

Along with the 0.44% already picked up from public shareholders through an open offer, JSW Paints now holds 61.2% of the company.

11 Dec 2025 1:43 AM

JSW Paints finalises 60.76% acquisition of Akzo Nobel India
(From Left to Right) Aswirbaad Das, Farhat Shaukat, Tashina, Tanya Kapool and Shyam Nair

10 Dec 2025 11:38 PM

Sunny Side Up strengthens Bengaluru team with senior hires
Gaurav Nijhawan

10 Dec 2025 3:49 PM

Gaurav Nijhawan joins MMTC-PAMP
Kia's 'The Next Legend' campaign.

10 Dec 2025 3:10 PM

Thierry Henry drives the next legend to the World Cup with Kia

Most Read

Among the 14 leaders revealed so far, only one is female

04 Dec 2025 2:53 PM

'Agency mergers are a sign of the times, but the lack of women leaders at the helm is more telling'
Aditya Kanthy

02 Dec 2025 12:35 AM

Omnicom-IPG merger: Creative structure for India revealed
Vineet Bajpai

01 Dec 2025 6:59 PM

Omnicom announces executive leadership after IPG merger
Manifest's December 2025 issue

01 Dec 2025 10:36 AM

Manifest's December 2025 issue is now out

Subscribe

* indicates required